do glp-1 agonists have cardiovascular benefit Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action Cardiovascular benefits of glucagon-like peptide-1

Benefits can include: Lower blood pressure Lower total cholesterol Better liver health for those with metabolic dysfunctionassociated steatotic liver disease (MASLD) Lower blood sugar and reduced diabetes risk Lower risk of kidney disease Tirzepatide and orforglipron are newer drugs that dont yet have results from long-term cardiovascular health trials

[DOI] [PubMed] [Google Scholar] 39.Varner VD, Taber LA

4 Cardiovascular Risk Reduction In addition to managing blood glucose levels and promoting weight loss, GLP-1 receptor agonists have been found to reduce the risk of cardiovascular events, which is a critical consideration in diabetic patients

States which previously had coverage such as California, New Hampshire, Pennsylvania and South Carolina have also eliminated GLP-1 coverage for weight loss in recent months

The bottom line: Retatrutide is promising to be a great tool for help with weight loss, but its not the only path forward for many people today